flag peptide has been researched along with tetradecanoylphorbol acetate in 1 studies
| Studies (flag peptide) | Trials (flag peptide) | Recent Studies (post-2010) (flag peptide) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 544 | 1 | 107 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harlan, JM; Karsan, A; Yee, E | 1 |
1 other study(ies) available for flag peptide and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1.
Topics: Apoptosis; Base Sequence; bcl-X Protein; Cell Line; Ceramides; Dactinomycin; DNA Primers; DNA-Binding Proteins; Endothelium, Vascular; Gene Expression; Homeodomain Proteins; Humans; Microcirculation; Minor Histocompatibility Antigens; Oligopeptides; Peptides; Polymerase Chain Reaction; Protein Kinase C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-jun; Replication Protein C; Repressor Proteins; Saccharomyces cerevisiae Proteins; Signal Transduction; Tetradecanoylphorbol Acetate; Transfection; Tumor Necrosis Factor-alpha | 1996 |